Suppr超能文献

髓样细胞特异性信号转导和转录激活因子3缺陷小鼠慢性结肠炎发生过程中髓样细胞与淋巴细胞之间的关键相互作用

Essential crosstalk between myeloid and lymphoid cells for development of chronic colitis in myeloid-specific signal transducer and activator of transcription 3-deficient mice.

作者信息

Reindl Wolfgang, Weiss Susanne, Lehr Hans-Anton, Förster Irmgard

机构信息

II Medizinische Klinik and Poliklinik, Klinikum rechts der Isar, Munich, Germany.

出版信息

Immunology. 2007 Jan;120(1):19-27. doi: 10.1111/j.1365-2567.2006.02473.x.

Abstract

Dysregulated cytokine responsiveness by myeloid cells can be a trigger for the development of chronic inflammation as well as inflammatory bowel disease. Thus, mice with a myeloid-specific defect in signal transducer and activator of transcription (Stat) 3 develop spontaneous colitis secondary to the inability of myeloid cells to respond to the immunosuppressive cytokine interleukin-10. We now examined whether the inflammation caused by Stat3-deficient macrophages is cell autonomous or dependent on their interaction with lymphocytes. For this purpose, myeloid-specific Stat3-deficient mice (LysMcre/Stat3(flox) mice) were intercrossed with RAG-1 knockout mice to generate LysMcre/Stat3(flox) RAG(-/-) mice. In these mutants and LysMcre/Stat3(flox) littermate control mice we determined the onset and severity of spontaneous chronic enterocolitis, and the reaction to dextran sodium sulphate (DSS)-induced epithelial damage, as well as to lipopolysaccharide (LPS) challenge. In contrast to LysMcre/Stat3(flox) mice, LysMcre/Stat3(flox) RAG(-/-) animals are protected from chronic enterocolitis. Although they respond to oral dextran sulphate with acute colitis symptoms, the inflammation heals similarly to wild type mice whereas LysMcre/Stat3(flox) mice exhibit continued colitis pathology. In addition, the hyperreactivity of LysMcre/Stat3(flox) mice to LPS-challenge in vivo was less severe in the absence of lymphocytes. Despite clear differences in the strength of inflammatory responses, macrophages of both LysMcre/Stat3(flox) mice and LysMcre/Stat3(flox) RAG(-/-) animals exhibited increased costimulatory capacity. In conclusion, our findings demonstrate that Stat3-deficient myeloid cells alone are not capable of inducing the severe pathology seen in LysMcre/Stat3(flox) mice. Yet when these cells can interact with lymphocytes their increased costimulatory potential will trigger an overshooting inflammatory response.

摘要

髓样细胞细胞因子反应失调可能是慢性炎症以及炎症性肠病发展的触发因素。因此,转录信号转导子与激活子(Stat)3存在髓样特异性缺陷的小鼠会继发自发性结肠炎,这是由于髓样细胞无法对免疫抑制性细胞因子白细胞介素-10作出反应所致。我们现在研究了Stat3缺陷型巨噬细胞引起的炎症是细胞自主性的还是依赖于它们与淋巴细胞的相互作用。为此,将髓样特异性Stat3缺陷型小鼠(LysMcre/Stat3(flox)小鼠)与RAG-1基因敲除小鼠杂交,以产生LysMcre/Stat3(flox) RAG(-/-)小鼠。在这些突变体和LysMcre/Stat3(flox)同窝对照小鼠中,我们确定了自发性慢性小肠结肠炎的发病情况和严重程度,以及对葡聚糖硫酸钠(DSS)诱导的上皮损伤、脂多糖(LPS)刺激的反应。与LysMcre/Stat3(flox)小鼠不同,LysMcre/Stat3(flox) RAG(-/-)动物可免受慢性小肠结肠炎的影响。尽管它们对口服葡聚糖硫酸钠会出现急性结肠炎症状,但炎症的愈合情况与野生型小鼠相似,而LysMcre/Stat3(flox)小鼠则表现出持续的结肠炎病理变化。此外,在没有淋巴细胞的情况下,LysMcre/Stat3(flox)小鼠体内对LPS刺激的高反应性也不那么严重。尽管炎症反应强度存在明显差异,但LysMcre/Stat3(flox)小鼠和LysMcre/Stat3(flox) RAG(-/-)动物的巨噬细胞共刺激能力均有所增强。总之,我们的研究结果表明,仅Stat3缺陷的髓样细胞不足以诱发LysMcre/Stat3(flox)小鼠中所见的严重病理变化。然而,当这些细胞能够与淋巴细胞相互作用时,其增强的共刺激潜能将引发过度的炎症反应。

相似文献

6
T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis.
Am J Physiol Gastrointest Liver Physiol. 2007 Jun;292(6):G1706-14. doi: 10.1152/ajpgi.00573.2006. Epub 2007 Mar 1.
7
MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
J Gastroenterol. 2005 Jan;40(1):16-23. doi: 10.1007/s00535-004-1492-9.
9
Regulation of gut inflammation and th17 cell response by interleukin-21.
Gastroenterology. 2008 Apr;134(4):1038-48. doi: 10.1053/j.gastro.2008.01.041. Epub 2008 Jan 17.
10
Pancreatic STAT3 protects mice against caerulein-induced pancreatitis via PAP1 induction.
Am J Pathol. 2012 Dec;181(6):2105-13. doi: 10.1016/j.ajpath.2012.08.038. Epub 2012 Oct 10.

引用本文的文献

1
expression in myeloid cells modulates the pathogenesis of dextran sulfate sodium (DSS)-induced colitis.
Front Immunol. 2023 May 22;14:1163987. doi: 10.3389/fimmu.2023.1163987. eCollection 2023.
2
Case report: promoter activity may define the alveolar macrophage dichotomy.
Front Immunol. 2022 Dec 12;13:1050494. doi: 10.3389/fimmu.2022.1050494. eCollection 2022.
3
The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients.
Cell Mol Gastroenterol Hepatol. 2022;14(1):35-53. doi: 10.1016/j.jcmgh.2022.03.008. Epub 2022 Apr 1.
4
The Emerging Role of Innate Immunity in Chronic Kidney Diseases.
Int J Mol Sci. 2020 Jun 4;21(11):4018. doi: 10.3390/ijms21114018.
6
STAT3 signaling in immunity.
Cytokine Growth Factor Rev. 2016 Oct;31:1-15. doi: 10.1016/j.cytogfr.2016.05.001. Epub 2016 May 9.
9
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.
Curr Neuropharmacol. 2015;13(3):324-68. doi: 10.2174/1570159x13666150307004545.
10
Genetically engineered mouse models for studying inflammatory bowel disease.
J Pathol. 2016 Jan;238(2):205-19. doi: 10.1002/path.4640. Epub 2015 Nov 14.

本文引用的文献

2
A critical role for Stat3 signaling in immune tolerance.
Immunity. 2003 Sep;19(3):425-36. doi: 10.1016/s1074-7613(03)00232-2.
3
SOCS3 regulates the plasticity of gp130 signaling.
Nat Immunol. 2003 Jun;4(6):546-50. doi: 10.1038/ni932. Epub 2003 May 18.
6
CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.
J Exp Med. 2003 Jan 6;197(1):111-9. doi: 10.1084/jem.20021345.
8
Mutational switch of an IL-6 response to an interferon-gamma-like response.
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8043-7. doi: 10.1073/pnas.122236099.
9
What does Stat3 do?
J Clin Invest. 2002 May;109(9):1143-8. doi: 10.1172/JCI15650.
10
Interleukin-10 and the interleukin-10 receptor.
Annu Rev Immunol. 2001;19:683-765. doi: 10.1146/annurev.immunol.19.1.683.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验